HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

mystixin 7

Also Known As:

4-anisoyl-arginyl-lysyl-leucyl-leucyl-thienyl-isoleucyl-leucinamide; mystixin-7; p-anisoyl-Arg-Lys-Leu-Leu-Thi-Ile-Leu-NH2

Networked: 3 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Amino Acids, Peptides, and Proteins: 1
- Peptides: 82426
  - Oligopeptides: 519
    - mystixin 7: 3

Experts

1.	Carlson, Kurt W: 1 article (08/2002)
2.	Shuster, Svetlana: 1 article (08/2002)
3.	Stair, Susan: 1 article (08/2002)
4.	Stern, Robert: 1 article (08/2002)
5.	Wei, Edward T: 1 article (08/2002)
6.	Gjerde, E A: 1 article (09/2000)
7.	Reed, R K: 1 article (09/2000)
8.	Wei, E T: 1 article (09/2000)
9.	Woie, K: 1 article (09/2000)

Related Diseases

1.	Neurogenic Inflammation 09/01/2000 - "Lowering of interstitial fluid pressure after neurogenic inflammation is inhibited by mystixin-7 peptide."
2.	Whooping Cough (Pertussis) 10/15/1995 - "Taken together, these results suggest that mystixin-7 and mystixin-11 interact with CRF receptors to activate pertussis-sensitive G proteins coupled to L-type Ca2+ channels that allow an uptake of extracellular Ca2+. Because U-73122, an inhibitor of 1,4,5-inositol trisphosphate production, partially inhibited the increase in [Ca2+]i, we measured inositol trisphosphates in cells stimulated by the two peptides. "
3.	Inflammation (Inflammations) 09/01/2000 - "Inflammation was produced by electrical stimulation (ES) of the vagus and the effects of the synthetic peptide mystixin-7 (p-anisoyl-Arg-Lys-Leu-Leu-D-Thi-Ile-D-Leu-NH(2)) on P(if) were examined. "
4.	Edema (Dropsy) 08/30/2002 - "As shown previously by this laboratory, the mystixin-7 peptide inhibits edema formation in vivo following intravenous administration at doses of less than 1.0 mg/kg. Mechanisms by which this peptide might suppress edema were examined here in vitro using cultured cells. "

Related Drugs and Biologics

1.	Peptides (Polypeptides)
2.	GTP-Binding Proteins (G-Protein)
3.	Corticotropin-Releasing Hormone Receptors (Corticotropin Releasing-Hormone Receptor)
4.	Inositol (Myoinositol)
5.	mystixin 11
6.	1- (6- ((3- methoxyestra- 1,3,5(10)- trien- 17- yl)amino)hexyl)- 1H- pyrrole- 2,5- dione

Related Therapies and Procedures

1.	Intravenous Administration